Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 09-2002 | 09-2001 | 03-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1 | -48 | -82 | 0 | N/A |
| Depreciation Amortization | 4 | 0 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -109 | 46 | N/A | N/A | N/A |
| Other Working Capital | -109 | 46 | 6 | N/A | N/A |
| Other Operating Activity | 212 | -45 | 60 | -105 | 0 |
| Operating Cash Flow | $N/A | $-2 | $-16 | $-105 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -1 | N/A |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-1 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 214 | N/A | 12 | 101 | N/A |
| Other Financing Activity | 0 | 0 | 6 | 0 | 0 |
| Financing Cash Flow | $214 | $N/A | $18 | $101 | $N/A |
| Beginning Cash Position | N/A | -2 | 0 | 5 | N/A |
| End Cash Position | N/A | N/A | 2 | 0 | N/A |
| Net Cash Flow | $214 | $-2 | $2 | $-5 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -2 | -16 | -105 | N/A |
| Capital Expenditure | N/A | N/A | N/A | -1 | N/A |
| Free Cash Flow | 0 | -2 | -16 | -106 | 0 |